Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 1999;54:44-50; doi:10.1136/thx.54.1.44
Copyright © 1999 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 1999;54:44-50 ( January )

Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA)

M Skov,a T Pressler,a H E Jensen,c N Høiby,b C Kocha

a Department of Pediatrics, b Department of Clinical Microbiology, c National University Hospital, Copenhagen, Denmark Department of Pharmacology and Pathobiology, The Royal Veterinary and Agricultural University, Copenhagen, Denmark

Correspondence to: Dr M Skov, Center of Cystic Fibrosis 5003, Department of Pediatrics GGK, Juliane Marie Centre, National University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.

Received 26 January 1998; Returned to authors 15 April 1998; Revised version received 6 July 1998; Accepted for publication 17 September 1998

BACKGROUND---IgG and IgG subclass antibodies to Aspergillus fumigatus (A fumigatus) were measured in a large population of patients with cystic fibrosis to elucidate a putative antibody pattern specific for allergic bronchopulmonary aspergillosis (ABPA).
METHODS---An ELISA technique using water soluble somatic hyphal (WSSH) A fumigatus antigens and subclass specific monoclonal antibodies was used for cross sectional quantification of IgG and IgG1-4 subclass antibody levels in the serum of 238 patients with cystic fibrosis and 107 healthy controls.
RESULTS---In patients with cystic fibrosis persistently colonised with A fumigatus the subclass antibody levels were significantly increased compared with patients with cystic fibrosis never or rarely colonised (p<0.001). The group of patients persistently colonised with A fumigatus with ABPA (+Af+ABPA) had significantly increased levels of IgG antibodies to A fumigatus (Af-IgG) (median 69 ELISA units (EU) versus 31) and of subclasses Af-IgG1 (91 versus 27), Af-IgG2 (143 versus 56), and Af-IgG4 antibodies (72 versus 20), but not of IgG3 (17 versus 15), compared with the colonised patients without ABPA (+Af-ABPA). Patients with cystic fibrosis with no or only rare isolates of A fumigatus without ABPA (-Af-ABPA) also had significantly increased subclass antibody levels (Af-IgG1 9 versus 3, Af-IgG2 28 versus 5, Af-IgG4 16 versus 4; p<0.001) compared with healthy controls. Low, although detectable, levels of antibodies were demonstrated in healthy controls. ABPA seemed to occur independently of Pseudomonas aeruginosa infection. Using diagnostic cut off levels for ABPA, sensitivity and specificity were calculated. The highest specificity was found for IgG4 (88%); sensitivity was between 65% and 73%. The positive predictive values (PPV) were moderate, whereas the negative predictive values (NPV) were high (96% in all subclasses except IgG3 with 94%). PPV increased to 50% if IgG1 as well as IgG2 and IgG4 were included.
CONCLUSIONS---In a large number of unselected patients with cystic fibrosis significantly increased levels of Af-specific antibodies belonging to total IgG and all four subclasses were found in all groups of patients compared with healthy controls. In patients persistently colonised with A fumigatus these levels were significantly higher than in non-colonised patients, and the significantly highest levels (with the exception of IgG3) were found in patients with ABPA. Using a sensitive ELISA technique, measurements of IgG and IgG subclass antibodies to A fumigatus might be of importance in the management of ABPA, especially as a screening test to exclude the presence of ABPA; other tests are needed to confirm the diagnosis.

Keywords: cystic fibrosis; allergic bronchopulmonary aspergillosis; IgG subclass antibodies


© 1999 by Thorax

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Latzin, P., Hartl, D., Regamey, N., Frey, U., Schoeni, M. H., Casaulta, C. (2008). Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 31: 36-42 [Abstract] [Full Text]  
  • Kraemer, R., Delosea, N., Ballinari, P., Gallati, S., Crameri, R. (2006). Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis. Am. J. Respir. Crit. Care Med. 174: 1211-1220 [Abstract] [Full Text]  
  • Banerjee, B., Kelly, K. J., Fink, J. N., Henderson, J. D. Jr., Bansal, N. K., Kurup, V. P. (2004). Modulation of Airway Inflammation by Immunostimulatory CpG Oligodeoxynucleotides in a Murine Model of Allergic Aspergillosis. Infect. Immun. 72: 6087-6094 [Abstract] [Full Text]  
  • Skov, M., Main, K.M., Sillesen, I.B., Muller, J., Koch, C., Lanng, S. (2002). Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 20: 127-133 [Abstract] [Full Text]  
  • Lyczak, J. B., Cannon, C. L., Pier, G. B. (2002). Lung Infections Associated with Cystic Fibrosis. Clin. Microbiol. Rev. 15: 194-222 [Abstract] [Full Text]  
  • Mastella, G., Rainisio, M., Harms, H.K., Hodson, M.E., Koch, C., Navarro, J., Strandvik, B., McKenzie, S.G. (2001). Allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 17: 1052-1053 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs